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ABSTRACT 
Eyes are the windows to the soul. Ayurvedic classical texts have mentioned 
about eye and its diseases since Vedic and Samhita kala, thus showing the 
importance of eye and ways to protect it. That is why eye care has been one 
of the priorities since the ages. In Ayurveda clinical features related to Dry 
eye are generally seen in Suskaksipaka.  
Over use of Video Display Terminals (V.D.T) like Computer, Mobiles, and 
Television & faulty lifestyle are some of the causes. Among these disorders, 
many are related to Indriya (Sensory Organ) especially Caksurindriya (Eye). 
In metro city, more than 50% cases from ophthalmic OPD are of Dry Eye 
Syndrome. Dry Eye Syndrome is a common ophthalmic condition, in its real 
sense is a problem for eye care practitioners due to its variegated 
etiologies, multi factorial physiopathology, lack of gold standard for 
diagnostic procedure. No curative treatment modalities are available and 
the palliative measures are inadequate too. It presents a great challenge to 
physicians. That’s why its prevalence is very high. It is 5% to 35% 
worldwide, while in India it is 29.25%. Dry Eye Syndrome also known as 
Kerato-Conjunctivitis Sicca (KCS) is considered a disease of the modern 
era. Dry eye syndrome, one of the most frequently encountered ocular 
morbidities, a growing public health problem and one of the most common 
conditions seen by the eye care practitioners. Tear secretion provides 
continuous moisture and lubrication on the ocular surface and provides 
oxygen to the corneal- epithelium. When the normal tear production is 
compromised, it leads to dry eyes. 
 
INTRODUCTION
 Śālākya Tantra is one of eight branches of 
Āyurveda which has evolved a long time ago. It deals 
with the etiology, diagnosis, prognosis, prevention 
and treatment of diseases that are located above the 
Ūrdhwa jatrugata i.e., eyes, nose, head and ears. In 
this branch the prime importance is given to Netra[1], 
as it is considered as Pradhāna among all Indriyas.  
 Dry eye syndrome (DES) is a multifactorial 
disorder of the tears and ocular surface[2] have 
clinical features like irritation, foreign body 
sensation, feeling of dryness, itching, non specific 
ocular discomfort, chronic sore eyes and 
photophobia etc[3]. For treatment the lubricating 
drops like- Carboxy methyl cellulose 0.5%, used 
which reduces the effects of Dry Eye, but its 
preservatives are harmful to eye. So long term use is 
not possible and effects of artificial drops are 
temporary. Also other treatment modalities or 
surgery are not accessible and not so effective. 
Therefore these limitations make us think about 
effective and alternative treatment for dry eye. This 
opens the door to other systems of medicine 
including Āyurveda to suggest and contribute 
alternative treatment modalities to check the 
suffering from dry eye.  
Śuskāksipāka 
One of the classification given by Ācārya 
Suśruta for eye diseases is “Diseases affecting all 
parts of eye ball i.e. Sarvagata Netraroga; includes 
disease Śuskāksipāka- a very similar to Ocular surface 
Review Article 
*Address for correspondence 
Dr. Rajesh Kumar Mishra 
Assistant Professor,  
Department of Dravyaguna, 
Patanjali Bhartiya Ayurvigyan 
Evum Anusandhan Sansthan, 
Haridwar, India.  
Email: 
drrajeshpyp@gmail.com  
Mob. No. 7895979176 
AYUSHDHARA, 2020;7(4):2805-2814 
 AYUSHDHARA | July - August 2020 | Vol 7 | Issue 4  2806 
disease i.e, Dry Eye Syndrome in modern 
opthalmology. Śuskāksipāka described as a Vātaja 
disease in Suśruta Saṁhitā[4]. Vātapitta vitiated 
condition by Vāgbhaṭa[5] and Śārañgadhara 
considered this as Vātaraktaja[6]. By analyzing these 
different opinions it is clear that vitiation of Vāta, 
Pitta, and Rakta play the major role in the disease 
pathology which makes the eye dry by reducing tear 
secretion or by changing the quality of tears, (Tear 
film defect). 
The Śuskāksipāka mentioned in Suśruta 
Saṁhitā is seem to be its early stage but description 
of Ācārya Vāgbhaṭa is that of well established 
advanced disease state with preponderance of Pāka -
inflammation and it is mainly due to vitiated Vāta and 
Pitta dosas. The disease is characterised by features 
such as Kuṇita vartma (inability to close lids), Dāruṇa 
and Ruksa vartma (hard, rough lids), Avila darẹsana 
(blurring of vision) and Dāruṇa Pratibodhana 
(difficulty in opening the lids)[7]. Ācārya Vaghbhaṭa 
mentioned additional features such as Gharsa 
(foreign body sensation), Toda (pricking pain), Bheda 
(tearing pain), Upadeha (stickiness of lids), Rūksatwa 
and Dāruṇatwa of Vartma and aksi (hardness and 
roughness of the eyelids and eye), Śīteksā (desire for 
cold), Śūla (Pain) and Pāka (Inflammation)[8]. The 
signs and symptoms of Śuskāksipāka frame a picture 
of dry eye syndrome in modern science.  
Dry Eye Syndrome 
Etymology: Dry eye is a synonym of Kerato-
conjuctivitis sicca. The term Kerato conjunctivitis 
sicca is made up of four words- ‘Kerato’, 
‘conjunctivus’, ‘itis’ and ‘sicca’. 
 The word ‘Kerato’ is derived from the Greek word 
‘Keras’ which means the cornea. 
 The word conjunctivus is derived from the Latin 
word ‘Conjungo’, which means, to join, owing to 
the fact that this membrane joins eyeball to the 
lids. 
 The word ‘itis’ is derived from the Greek word 
‘ites’ used as an adjectival suffix denoting 
inflammation of the part indicated by the word 
stem to which it is attached. 
 The word ‘sicca’ is derived from the Latin word 
‘Siccus’ which means dry or dryness.[9,10] 
Definition: According to AAO 2013 defined dry eye 
as: 
“Dry eye is a common ocular condition that has a high 
impact on the quality of life of afflicted individuals 
owing to discomfort or visual disability. Although the 
symptoms improve with treatment, the condition is 
usually not curable. Dry eye can be a cause of visual 
disability and may compromise results of corneal, 
cataract and refractive surgery. 
Epidemiology: The prevalence of dry eye has not 
been determined accurately due the lack of a single 
definition of the condition as well as variability of 
criteria included in several studies. However the 
large number of studies carried out in various 
countries estimate the prevalence of dry eye disease 
to be between 5-34 percent. The Baever Dam study 
demonstrated as incidence of dry eye of 13.3 percent 
that significantly correlated with patient age.[11] Dry 
eye is apparently higher in women (57.2%) than man 
(51%) in India. Being a heterogeneous group of 
conditions with multifactorial etiologies, prevalence 
vary with the many subcategories of the diseases. 
Prevalence of dry eye increased with age, sex, current 
smoking history, ophthalmic surgeries, contact lens 
wear and coexisting ocular conditions like 
meibomian gland dysfunction, terygium, blepharitis, 
and conjunctival diseases. Dry eye disease is more 
frequently found in patients with arthritis, thyroid 
dysfunction and poor general health.  
Risk Factors for Dry Eye Syndrome 
Dry eye is one of the most frequent 
ophthalmologic conditions which can be produced by 
hundreds of causes. Diseases causing dry eye are 
almost always chronic, progressive and produce mild 
or moderate manifestations but in severe cases it 
causes discomfort and severe low vision. Some risk 
factors which are responsible for dry eye Syndrome 
are as follows: 
 Physiological conditions- Slowing of the blink 
rate increases the blink interval and increases the 
period of evaporative loss between each blink.[12] 
 Anatomical Conditions- Height of the palpebral 
is wider in upgaze than down gaze.[13] Evaporative 
loss per eye increases with increasing palpebral 
width and is therefore, increased in upgaze.[14] 
 Sex Hormones- Low levels of androgens and high 
levels of estrogens are risk factors for dry eye. 
Androgens promote lacrimal and meibomian 
glands function.[15] Female sex and Post-
menopausal estrogen therapy are important risk 
factors for dry eye.[16] 
 Systemic drugs- Some systemic medicines have a 
collateral exocrinic hyposecretory effect. Among 
them are antidepressants, anxiolytics, sleeping 
pills, antiparkinsonian, diuretics, vascular 
antihypertensive, anticholinergic, antihistaminic 
and antiarrhythmic; besides some preservatives 
used in ocular medications can cause the disease. 
 Aging- It is associated with physiological changes 
that may predispose dry eye, including decrease in 
tear volume and flow, increased osmolarity,[17] 
decreased tear film stability and alteration in the 
composition of the meibomian lipids.[18] 
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 Environmental factors- Evaporative water loss 
from the eye is increased in conditions of low 
relative humidity, occurring either as part of 
natural variation at different geographic locations 
or in special circumstances created by air 
conditioning, air travel or other artificial 
environments.[19] Similarly, tear evaporation is 
increased by exposure to high wind velocity. 
 Occupational factors- It may cause a slow blink 
rate, representing a risk for dry eye in those 
working with video display terminals.[20] 
Pathogenesis 
 Dry eye is recognized as a disturbance of the 
Lacrimal Functional Unit (LFU), an integrated system 
comprising the lacrimal glands, ocular surface 
(cornea, conjunctiva and meibomian glands) and lids, 
and the sensory and motor nerves that connect 
them.[21] The core mechanisms of dry eye are driven 
by tear hyperosmolarity and tear film instability. The 
major causes of tear hyperosmolarity are reduced 
aqueous tear flow, resulting from lacrimal failure, 
and/or increased evaporation from the tear film. 
Increased evaporative loss is favored by 
environmental conditions of low humidity and high 
air flow and may be caused clinically, in particular, by 
meibomian gland dysfunction (MGD), which leads to 
an unstable tear film lipid layer. Reduced aqueous 
tear flow is due to impaired delivery of lacrimal fluid 
into conjunctival sac. Tear delivery may be 
obstructed by cicatricial conjunctival scarring or 
reduced by a loss of sensory reflex drive to the 
lacrimal gland from the ocular surface. Eventually, 
the chronic surface damage of dry eye leads to a fall 
in corneal sensitivity and a reduction of reflex tear 
secretion (Fig. 1 & 2).[22]  
Classification based on etiopathogenesis 
Aqueous Tear Deficient Dry Eye[23]  
It occurs due to either decreased secretion of tears or 
inability of the secreted tears to reach the ocular 
surface. This is subdivided into two categories:  
 Sjogren’s syndrome tear deficiency (SSTD)  
 Non-Sjogren’s tear deficiency(NSTD)  
The former (NSTD) has definite association with 
autoimmune systemic diseases, where as the latter 
(SSTD) has no relationship with it.  
 Sjogren’s tear deficiency: Decreased tear 
secretion occurs in Sjögren’s syndrome which is a 
chronic inflammatory disorder characterized by 
lymphocytic infiltration of exocrine glands, 
especially the lacrimal and salivary glands. The 
condition may be primary or secondary.  
 The primary Sjögren’s syndrome is characterized 
by dry eyes with dry mouth, a positive focus score 
on minor salivary gland biopsy and positive serum 
autoantibodies like antinuclear antibody (ANA), 
rheumatoid factor or Sjögren’s syndrome specific 
autoantibodies like anti-Ro (SS-A) and anti La 
(anti- SS-B).  
 Secondary Sjögren’s syndrome is characterized by 
the presence of systemic connective tissue 
disorder like rheumatoid arthritis, systemic lupus 
erythematosus and scleroderma along with the 
features of primary Sjögren’s syndrome.  
 Non-Sjogren’s tear deficiency: This condition is 
not associated with any clinical manifestations or 
systemic features of autoimmune disease. The 
largest category of patients who have dry eye 
syndrome comprises those with acquired primary 
lacrimal gland deficiency and idiopathic kerato 
conjunctivitis sicca syndrome.  
Evaporative dry eye: It may be intrinsic, where the 
regulation of evaporative loss from the tear film is 
directly affected and extrinsic evaporative dry eye 
embraces those etiologies that increase evaporation 
by their pathological effects on the ocular surface. 
Intrinsic causes 
 Meibomian gland dysfunction: It is the most 
common cause of evaporative dry eye. Its multiple 
causes and associations include dermatoses, such 
as acne rosacea, seborrheic dermatitis and atopic 
dermatitis.[24] MGD can be primary or secondary, 
simple or cicatricial. 
 Disorders of lid aperture and lid/globe 
congruity or dynamics: Endocrine exophthalmos 
and specifically increased palpebral fissure width 
is associated with ocular drying and tear 
hyperosmolarity.[25] Increasing palpebral fissure 
width correlates with increased tear film 
evaporation.[26] 
 Low blink rate: Drying of the ocular surface may 
be caused by a reduced blink rate, which lengthens 
the period during which the ocular surface is 
exposed to water loss before the next blink.[27] 
Extrinsic Causes 
 Ocular surface disorders: Disease of the exposed 
ocular surface may lead to imperfect surface 
wetting early tear film breakup, tear 
hyperosmolarity, and dry eye. 
 Vitamin A deficiency: Vitamin A is essential for 
the development of goblet cells in mucous 
membrane and the expression of glycocalyx 
mucins. Vitamin A deficiency can cause lacrimal 
acinar damage and therefore some patients with 
xerophthalmia may have a lacrimal, aqueous tear 
deficient dry eye.[28] 
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 Topical drugs and preservatives: Many 
components of eye drop formulations can induce a 
toxic response from the ocular surface. Of these, 
the most common offenders are preservatives, 
such as benzalkonium chloride (BAC), which 
causes surface epithelial cell damage and punctate 
epithelial keratitis, which interferes with surface 
wet ability.[29] 
 Contact lens wear: Poor lens wet ability, could be 
a basis for a higher evaporative loss during lens 
wear and was attributed to potential changes in 
tear film lipid composition, rather than to a loss of 
meibomian gland oil delivery.[30] 
 Allergic conjunctivitis: The general mechanism 
leading to disease is that exposure to antigen leads 
to degranulation of Ig-E primed mast cells, with 
the release of inflammatory cytokines. Surface 
epithelial cell death occurs, affecting conjunctival 
and corneal epithelium (punctate kerato-
conjuctivitis). Surface damage and the release of 
inflammatory mediator’s leads to allergic 
symptoms and to reflex stimulation of the normal 
lacrimal gland.[31] 
Classification based on causative mechanism 
 Tear hyperosmolarity: Tear hyperosmolarity 
arises as a result of water evaporation from the 
exposed ocular surface, in situations of a low 
aqueous tear flow, or as a result of excessive 
evaporation and as a combination of these 
events.[32] 
 Tear film instability: Tear film instability may be 
due to disturbance of ocular surface mucins 
(xerophthalmia) and due to allergic eye disease.[33] 
Classification based on symptoms 
Triple classification 
 Symptoms when overexposed- Mild dry Eye 
syndrome  
 Symptoms+reversible signs (eg. Epithelial 
erosions)- Moderate dry eye syndrome 
 Symptoms+permanent signs (eg. Corneal ulcers)- 
Severe dry eye syndrome 
 Symptoms+permanent signs and subnormal 
vision- Disabling (dry eye syndrome) 
Symptoms 
 Foreign body sensation 
 Burning or itching 
 Fluctuating vision 
 Grittiness or irritation 
 Sore or tired eyes 
 Feeling of dryness 
 Ocular discharge 
 Photophobia 
 Contact lens intolerance 
 Watering or excessive tearing 
These symptoms characteristically worsen during the 
day. A history of exacerbation by reading, computer 
use or in windy environment is often elicited.[34] 
Signs: 
 External observation of the face for acne rosacea. 
 Lids and lashes- Examined for lagophthalmos, 
infrequent blinking, floppy eyelids, lid retraction, 
ectropian, entropion, notching, trichiasis and 
distichiasis. 
 Lid margins: Observations of meibomian gland 
architecture and openings, presence of 
blepharitis, telengectasia and position and size of 
lacrimal puncta. Enlargement of lacrimal gland 
and function of 5th & 7th cranial nerves has to be 
checked.  
 Conjunctiva: It may show mild redness and 
keratinization. 
 Tear film: Marginal tear meniscus, presence of 
foam or debris suggestive of meibomian gland 
dysfunction. In the dry eye syndrome, lipid 
contaminated mucin accumulates in the tear film 
as particles and debris that move with each blink. 
 Cornea: Punctate epithelial erosions in the 
interpalpebral and inferior cornea. 
 Mucus filaments: stain with Rose Bengal. 
 Mucus Plaques: Composed of mucus epithelial 
cells. 
Classification based on severity 
For a classification of dry eye on the basis of 
severity, the Delphi Panel Report[35] was adopted and 
modified as a third component of the DEWS (Table 
1). 
Table 1 Classification based on severity 
Dry eye severity 
level 
1 2 3 4 
Discomfort, Severity 
and frequency 
Mild and/or 
episodic; occurs 
environmental 
stress 
Moderate 
episodic or 
chronic, stress or 
no stress 
Severe frequent or 
constant without 
stress 
Severe and/or 
disabling and constant 
Visual Symptoms None or episodic Annoying and/or Annoying, chronic Constant and/or 
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mild fatigue activity limiting 
episode 
and/or constant, 
limiting activity 
possibly disabling 
Conjunctival injection None to mild None to mild Mild to moderate Marked 
Conjuctival staining None to mild Variable Moderate to marked Marked 
Corneal staining None to mild Variable Marked central Severe punctate 
erosions 
Corneal/ tear signs 
mucus 
None to mild Mild debris, 
decreased 
meniscus 
Filamentary keratitis, 
mucus clumping, 
increased tear debris 
Filamentary keratitis, 
mucus clumping, 
increased tear debris, 
ulceration 
Lid/Meibomian 
glands 
MGD variably 
present 
MGD variably 
present 
Frequently present Trichiasis, 
keratinization, 
symblepharon 
TFBUT (sec) Variable ≤10 ≤5 Immediate 
Schirmer’s Score 
(mm/5min) 
Variable ≤10 ≤5 ≤2 
Diagnosis
Objective tests: Quantitative tests 
Schirmer’s test: It is an invasive test in which a strip 
of filter paper is placed in lower conjunctival cul-de-
sac and measurement of wetting length is done over 
a certain period of time. There are two commonly 
used variants of Schirmer’s test.[36] 
Schirmer’s’ I: Measures the total tear production 
including both basal and reflex tears. Jones 
modifications of this test can measures only basal 
secretion with the aid of an anesthetic agent. 
Schirmer’s II: Schirmer’s II test is performed by 
irritating the nasal mucosa with cotton – tipped 
applicator prior to measuring tear production, which 
is mainly used for measuring the reflex tear 
secretion of main lacrimal gland. 
Schirmer’s III: This test is obsolete now as in this 
measurement was done with the subject staring at 
sun. A value of less than 5mm wetting in 5 minutes is 
considered abnormal for both tests. A 1- minute 
(with anesthesia) and 2-minutes Schirmer’s test has 
been suggested, with cut-offs of 6mm and 10mm 
(99% confidence interval), respectively. It has been 
found to lack accuracy and reproducibility. 
Qualitative Tests 
Tear Film break-up time: The tear break-up time 
(TFBUT) is defined as the time interval between a 
complete blink and the first appearance of a dry spot 
in the tear film after preservative free fluorescein 
administration. A TFBUT of less than 10 seconds 
suggests tear film instability, and less than 5 seconds 
suggests definite dry eye. 
 Factors, which reduce the reliability/reproducibility 
of this test include: 
 Volume of fluorescein administered 
 Preservatives, such as benzalkonium chloride 
shorten the TFBUT 
 Superficial punctate keratopathy 
There are non-fluorescein (noninvasive) 
measurements of TFBUT that employ reflective 
devices with a grid projected onto the corneal 
surface. These values are slightly higher that the 
invasive technique.[37] 
Treatment [38] 
The underlying causative processes of dry 
eye generally not reversible and management is 
therefore structured around the control of the 
symptoms and the prevention of surface damage. 
DEWS have produced guidelines based on earlier 
International Taskforce guideline for Dry eye, in 
which suggested treatment options depend on the 
level of severity of disease graded from 1 to 4. The 
DEWS guidelines can also be applied in a graded 
approach, proceeding to the next level if the 
preceding measures are inadequate. 
Level 1 
A) Education and environmental/dietary 
modifications 
 Establishment of realistic expectations and 
emphasis on the importance of compliance. 
 Lifestyle review including the importance of 
blinking whilst reading, watching television or 
using a computer screen and the management 
of contact lens wear. 
 Environmental review, e.g. increasing humidity 
may be possible for some environments. 
 Instillation aids for eye drops should be 
advocated for patients with reduced dexterity. 
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 Caution the patient that laser refractive surgery 
can exacerbate dry eye. 
B) Systemic medication review to exclude 
contributory effects and eliminate offending agents, 
discontinuation of toxic/ preserved of topical 
medication if possible. 
C) Artificial tears substitutes including gel and 
ointments- Use of preserved drops and gel. 
D) Eye lid therapy- Basic measures such as warm 
compresses and lid hygiene for blepharitis; 
reparative lid surgery (eg. Entropion, ectropion, 
excessive lid laxity or scleral show) may be 
considered as an early measure. Nocturnal 
lagophthlmos can be addressed by taping the lid 
closed at bedtime, wearing swimming goggles 
during sleep or in extreme cases by lateral 
tarsorraphy. 
Level 2 
A. Non- preserved tear substitutes are categorized 
as level 2 treatments. 
B. Anti inflammatory agents such as topical 
steroids, oral omega fatty acids and other 
agents such as topical cyclosporin. 
C. Tetracyclins (for meibomitis, rosacea) 
D. Punctal plugs 
E. Secretagouges e.g. Pilocarpine, cevilamine, 
rebamipide 
F. Moisture chamber spectacles and spectacle side 
shields 
Level 3 
A. Serum eye drops Autologous or umblical cord 
serum 
B. Contact lenses 
C. Permanent punctal occlusion 
Level 4 
A. Systemic anti-inflammatory agents. 
B. Surgery 
 Eye lid surgery, such as tarsorrhaphy 
 Salivary gland auto transplantation 
 Mucous membrane or amniotic membrane 
transplantation for corneal complications. 
Tear Substitutes: Tear substitutes have a relatively 
simple formulation that cannot approximate the 
complex components and structure of the normal 
tear film. Their delivery is also periodic rather than 
continuous. In theory, the ideal artificial lubricant 
should be preservative free, contain potassium, 
bicarbonate and other electrolytes and have a 
polymeric system to increase its retention time [39]. 
 
 
Drops and gels 
 Cellulose derivatives (e.g. hypromellose, 
methylcellulose) are appropriate for mild cases. 
 Carbomer gels adhere to the ocular surface and 
so are longer- lasting, but some patients are 
troubled by slight blurring. 
 Other agents include polyvinyl alcohol (PVA), 
which increases the persistence of the tear film 
and is useful in mucin deficiency, sodium 
hyaluronate, povidone, glycerine, propylene 
glycol, polysorbate and others. 
 Diquafosol is a newer agent that works as a 
topical secretagogue. 
Ointments containing petroleum mineral oil can be 
used at bedtime to supplement daytime drops or gel 
instillation; marked blurring precludes day time 
use. Some practitioners do not prescribe these for 
long-term use.  
Eyelid Spray:  It is applied to the closed eye and 
typically contains a liposome-based agent that may 
stabilize the tear film and reduce evaporation. 
Artificial Tear: Inserts emplaced once or twice 
daily offer extended duration treatment and are 
preferred by some patients.  
Mucolytic agents: Acetylcysteine 5% drop may be 
useful in patients with corneal filaments and 
mucous plaques which acetylcysteine dissolve. It 
may cause stinging or installation. Acetylcysteine is 
malodorous and has a limited shelf life. Manual 
debridement of filaments may also be useful. 
Non-preserved drops: Preservatives can be a 
potent source of toxicity, especially after punctal 
occlusion. Numerous non preserved drops are now 
available, including some multi-dose products and 
in general should be used in preference to 
preservative containing preparations in any more 
than mild diseases or with installation more than 
three or four times daily. 
Punctal occlusion: Punctal occlusion reduces 
drainage and thereby preserves natural tears and 
prolongs the effect of artificial tears. It is of greatest 
value in patients with moderate to severe KCS who 
have not responded to frequent installation of 
topical agents.  
Temporary Occlusion can be achieved by inserting 
collagen plug in to canaliculi; these dissolve over a 
number of weeks. 
Reversible prolonged occlusion can be achieved 
with silicone or long acting (2-6 months) collagen 
plugs. 
Permanent occlusion should be undertaken only in 
patients with severe dry eye who have had a 
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positive response to temporary plugs without 
epiphora. 
Anti- inflammatory agents 
Topical steroids generally low intensities 
preparations such as fluorometholone, are effective 
supplementary treatment for acute exacerbations. 
Omega fatty acids supplements (e.g. Omega-3 fish 
oil, flex seed oil) can have a dramatic effect on 
symptoms and may facilitate the reduction of 
topical medication. 
Oral tetracyclines for an extended course, 
often 3 months at a relatively low dose, may control 
associate blepharitis, especially meibomitis and 
reduced tear levels of inflammatory mediators. 
Topical cyclosporin (usually 0.05%) reduces T-cell 
mediated inflammation of lacrimal tissue, resulting 
in an increase in the number of Goblet cells and 
reversible of squamous metaplasia of the 
conjunctiva. 
Contact lenses 
Although contact lens wear can exacerbate 
dry eye, particularly due to inflammatory, sensory 
and evaporative effects, these can be out weighted 
by the reservoir effect of fluid trapped behind the 
lens, and they are effective at relieving symptoms 
from secondary corneal changes. Patients should be 
cautioned regarding the possibility of bacterial 
keratitis. 
 Low water content hydroxyl ethyl metha 
acrylate (HEMA) lenses may be successfully 
fitted to moderately dry eye.  
 Silicon rubber lenses that contain no water and 
readily transmit oxygen are effective in 
protecting the cornea in extreme tear film 
deficiency, although deposition of debris on the 
surface of the lens can blur vision and be 
problematic. The continued availability of these 
lenses is in doubt. 
 Occlusive gas permeable scleral contact lenses 
provide a reservoir of saline over the cornea. 
They can be worn on an extremely dry with 
exposure.  
Optimization of environmental humidity 
 Reduction of room temperature to minimize 
evaporation of tears. 
 Room humidifiers may be tried but are 
frequently disappointing because much 
apparatus is incapable of significantly 
increasing the relative humidity of an average 
sized room. 
Miscellaneous options 
 Botulin toxin injection  
 Oral cholinergic agonists 
 Submandibular gland transplantation 
 Serum eye drops 
Fig. 1: Etiopathogenesis of Dry Eye Diseases 
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DISCUSSION 
In Śuskāksipāka i.e. Dry Eye Syndrome there 
is dryness in eyes due to increase in Vāta-Paitta-
dosa prakopa, vitiated Vāta and Pitta reach upto 
Netra (Prasara-Sthānasaṁśraya) by the Śira. At 
Netra they vitiated Rakta dhātu to form 
Śuskāksipāka, which results in the scanty Aśru, so as 
to form dry eye.  
In Ayurvedic literature various treatment 
modalities are applicable in treating Śuskāksipāka 
including Snehpana, Tarpaṇa, Putpāka, Nasya, 
Añjana etc. Thus it may reduce the dryness of the 
eyes, irritation and inflammation occurring in the 
eyes. In the present scenario we understanding of 
the disease Śuskāksipāka (Dry Eye Syndrome) and 
planning the treatment protocol accordingly; has 
proved much effective than the prevailing 
management modalities.  
CONCLUSION 
The eye is the main sense organ gifted by 
God to human beings. An individual who is blind, 
day and night are the same and this beautiful world 
is of no use to him even if he possesses a lot of 
wealth, so sincere efforts should be made by every 
individual to preserve his/her vision till the last 
breath of life. In spite of remarkable progress and 
advances in the field of modern ophthalmology, 
there are some limitations. Āyurveda, the ancient 
system of medicine gives valuable guide lines not 
only in treatment aspects but also in preventive 
line. Netra Kriyā kalpa like Snehpana, Tarpaṇa, 
Puṭpāka, Nasya, Añjana is one of the local 
therapeutic procedure which if promptly used 
shows objective evidences of excellent responses. 
The systemic approach to treat the disease 
Śuskāksipāka, (Sarvagata Vāta-Pitta/Raktaja Netra 
Roga) and managing this humeral imbalance, along 
with local/ topical therapeutically procedures, the 
condition could be managed well. According to 
Āyurveda, dry eye is not merely an ocular surface 
disorder, rather this is one of manifestation of the 
deranged metabolism of body tissues. Aśru (tear 
film) is the by product of Rasa, Meda, and Majjā 
dhātu and without normalizing/altering them we 
cannot treat dry eye syndrome optimally.  
Thus, as we can conclude that the dry eye 
syndrome is a condition for which modern medicine 
has no treatment except for the symptomatic 
management; the treatment and approach of 
Ayurvedic system of medicine according to the 
Dosas provided both subjective and objective relief 
to the patient.  
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